Modafinil blocks reinstatement of extinguished opiate-seeking in rats: Mediation by a glutamate mechanism

Neuropsychopharmacology

Volumn 35, Issue 11, 2010, Pages 2203-2210

  Tahsili Fahadan, Pouya ^a   Carr, Gregory V ^b   Harris, Glenda C ^b   Aston Jones, Gary ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

conditioned place preference; metabotropic glutamate receptors; modafinil; morphine; reinstatement; relapse

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; GLUTAMIC ACID; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; MODAFINIL; MORPHINE; OPIATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SEEKING BEHAVIOR; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REINFORCEMENT; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ADDICTIVE; BENZHYDRYL COMPOUNDS; CONDITIONING (PSYCHOLOGY); EXTINCTION, PSYCHOLOGICAL; GLUTAMIC ACID; MALE; MORPHINE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 78651270848     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.94     Document Type: Article

References (43)

1. Aguilar MA, Rodriguez-Arias M, Minarro J (2009). Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev 59: 253-277.
2. Anderson AL, Reid MS, Li SH, Holmes T, Shemanski L, Slee A et al (2009). Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend 104: 133-139.
3. Bardo MT, Bevins RA (2000). Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl) 153: 31-43.
4. Bernardi RE, Lewis JR, Lattal KM, Berger SP (2009). Modafinil reinstates a cocaine conditioned place preference following extinction in rats. Behav Brain Res 204: 250-253.
5. Bossert JM, Busch RF, Gray SM (2005a). The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking. Neuroreport 16: 1013-1016.
6. Bossert JM, Ghitza UE, Lu L, Epstein DH, Shaham Y (2005b). Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur J Pharmacol 526: 36-50.
7. Bossert JM, Gray SM, Lu L, Shaham Y (2006). Activation of group II metabotropic glutamate receptors in the nucleus accumbens shell attenuates context-induced relapse to heroin seeking. Neuropsychopharmacology 31: 2197-2209.
8. Bossert JM, Liu SY, Lu L, Shaham Y (2004). A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking. J Neurosci 24: 10726-10730.
9. Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP (2005). A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30: 205-211.
10. de Wit H, Stewart J (1983). Drug reinstatement of heroin-reinforced responding in the rat. Psychopharmacology (Berl) 79: 29-31.
11. Deroche-Gamonet V, Darnaudery M, Bruins-Slot L, Piat F, Le Moal M, Piazza PV (2002). Study of the addictive potential of modafinil in naive and cocaine-experienced rats. Psychophar-macology (Berl) 161: 387-395.
12. Ferraro L, Antonelli T, O'Connor WT, Tanganelli S, Rambert F, Fuxe K (1997). The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus. Neurore-port 8: 2883-2887.
13. Ferraro L, Antonelli T, O'Connor WT, Tanganelli S, Rambert FA, Fuxe K (1998). The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neurosci Lett 253: 135-138.
14. Ferraro L, Antonelli T, Tanganelli S, O'Connor WT, Perez de la Mora M, Mendez-Franco J et al (1999). The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology 20: 346-356.
15. Ferraro L, Tanganelli S, O'Connor WT, Antonelli T, Rambert F, Fuxe K (1996). The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor. Neurosci Lett 220: 5-8.
16. Gass JT, Olive MF (2008). Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol 75: 218-265.
17. Harris GC, Aston-Jones G (2003a). Altered motivation and learning following opiate withdrawal: evidence for prolonged dysregula-tion of reward processing. Neuropsychopharmacology 28: 865-871.
18. Harris GC, Aston-Jones G (2003b). Enhanced morphine preference following prolonged abstinence: association with increased Fos expression in the extended amygdala. Neuropsychopharmacology 28: 292-299.
19. Harris GC, Wimmer M, Aston-Jones G (2005). A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437: 556-559.
20. Hart CL, Haney M, Vosburg SK, Rubin E, Foltin RW (2008). Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 33: 761-768.
21. Hellriegel ET, Arora S, Nelson M, Robertson Jr P (2001). Steady-state pharmacokinetics and tolerability of modafinil given alone or in combination with methylphenidate in healthy volunteers. J Clin Pharmacol 41: 895-904.
22. Ishizuka T, Murakami M, Yamatodani A (2008). Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats. Eur J Pharmacol 578: 209-215.
23. Jaffe JH, Cascella NG, Kumor KM, Sherer MA (1989). Cocaine-induced cocaine craving. Psychopharmacology (Berl) 97: 59-64.
24. Knackstedt LA, Kalivas PW (2009). Glutamate and reinstatement. Curr Opin Pharmacol 9: 59-64.
25. Knackstedt LA, Moussawi K, Lalumiere R, Schwendt M, Klugmann M, Kalivas P (2010). Extinction training after cocaine self-administration induces glutamatergic plasticity to inhibit cocaine seeking. J Neurosci 30: 7984-7992.
26. LaLumiere RT, Kalivas PW (2008). Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci 28: 3170-3177.
27. Makris AP, Rush CR, Frederich RC, Taylor AC, Kelly TH (2007). Behavioral and subjective effects of D-amphetamine and modafinil in healthy adults. Exp Clin Psychopharmacol 15: 123-133.
28. Malcolm R, Swayngim K, Donovan JL, DeVane CL, Elkashef A, Chiang N et al (2006). Modafinil and cocaine interactions. Am J Drug Alcohol Abuse 32: 577-587.
29. Markou A (2007). The role of metabotropic glutamate receptors in drug reward, motivation and dependence. Drug News Perspect 20: 103-108.
30. Martinez-Raga J, Knecht C, Cepeda S (2008). Modafinil: a useful medication for cocaine addiction? Review of the evidence from neuropharmacological, experimental and clinical studies. Curr Drug Abuse Rev 1: 213-221.
31. Minzenberg MJ, Carter CS (2008). Modafinil: a review of neurochemical actions and effects on cognition. Neuropsycho-pharmacology 33: 1477-1502.
32. Moran MM, McFarland K, Melendez RI, Kalivas PW, Seamans JK (2005). Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J Neurosci 25: 6389-6393.
33. Myrick H, Malcolm R, Taylor B, LaRowe S (2004). Modafinil: preclinical, clinical, and post-marketing surveillanceFa review of abuse liability issues. Ann Clin Psychiatry 16: 101-109.
34. Nutt D, Lingford-Hughes A (2008). Addiction: the clinical interface. Br J Pharmacol 154: 397-405.
35. O'Brien CP (1997). A range of research-based pharmacotherapies for addiction. Science 278: 66-70.
36. Perez de la Mora M, Aguilar-Garcia A, Ramon-Frias T, Ramirez-Ramirez R, Mendez-Franco J, Rambert F et al (1999). Effects of the vigilance promoting drug modafinil on the synthesis of GABA and glutamate in slices of rat hypothalamus. Neurosci Lett 259: 181-185.
37. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003). The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168: 3-20.
38. Shalev U, Grimm JW, Shaham Y (2002). Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54: 1-42.
39. Stewart J (1983). Conditioned and unconditioned drug effects in relapse to opiate and stimulant drug self-adminstration. Prog Neuropsychopharmacol Biol Psychiatry 7: 591-597.
40. Stoops WW, Lile JA, Fillmore MT, Glaser PE, Rush CR (2005). Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychophar-macology (Berl) 182: 186-193.
41. Vansickel AR, Fillmorex MT, Hays LR, Rush CR (2008). Effects of potential agonist-replacement therapies for stimulant dependence on inhibitory control in cocaine abusers. Am J Drug Alcohol Abuse 34: 293-305.
42. Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F et al (2009). Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 301: 1148-1154.
43. Wong YN, Simcoe D, Hartman LN, Laughton WB, King SP, McCormick GC et al (1999). A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and toler-ability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 39: 30-40.